Pison Announces Investment from Samsung Ventures, Strengthening Strategic Presence in Consumer Wearables for Neurocognitive Performance

Pison, the trailblazer in AI-powered neural sensors for cognitive health, wellness, and gesture control, today announced an equity investment from Samsung Venture Investment Corporation (Samsung Ventures). This investment highlights the dedication of Samsung Ventures to advancing future healthcare technology and acknowledges Pison’s potential in neurocognitive assessment and tracking capabilities.

“Our mobile apps and subscription services aim to redefine cognitive performance and productivity—whether at home, on the athletic field, in the workplace, or within mission-critical job functions.”

HealthTech Insights: Empower AI Awarded U.S. Army Task Order to Modernize Health Networks

Pison was founded in 2016 with funding from the Massachusetts Institute of Technology, National Science Foundation, and the ALS Association. The company has also received funding from several Small Business Innovation Research (SBIR) awards from the U.S. Department of Defense, and various research institutions. In addition, the FY2025 c (NDAA) highlights the value of neural biosensors for advancing warfighter health and readiness, namely detecting traumatic brain injuries and tracking chronic fatigue.

Pison’s innovative sensor technology detects brain activity from three nerve bundles in the wrist. Using both active and passive AI algorithms, it extracts neurocognitive data, providing insights into mental acuity and impairment from poor sleep, chronic fatigue, anxiety, neurodegenerative conditions, drugs, alcohol, and subconcussive brain injuries.

HealthTech Insights: Deciphex Secures $32.3M Series C to Address Global Pathology Shortage

“We’re honored to have Samsung Venture Investment Corporation involved in this funding journey for Pison, as their support offers vital resources to bring forward transformative solutions with meaningful societal impact,” said John Croteau, CEO of Pison. “Our mobile apps and subscription services aim to redefine cognitive performance and productivity—whether at home, on the athletic field, in the workplace, or within mission-critical job functions.”

HealthTech Insights: Anumana and AliveCor Collaborate to Advance ECG-AI Algorithms for Early Detection of Cardiac Diseases on Kardia Devices

To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com

Source – businesswire

Tags: Massachusetts Institute of Technology, Pison, Samsung Venture Investment Corporation, Small Business Innovation Research, U.S. Department of Defense

HealthTech Media Room

HealthTech Media Room is a leading B2B media publication platform providing in-depth coverage of the rapidly evolving healthcare technology and academic research sectors. Specializing in key focus areas such as MedTech, Pharma, Digital Health, Health IT, and Biotech, HealthTech Media Room delivers the latest news, trends, and insights across the entire HealthTech landscape. From breakthrough medical devices and innovative pharmaceuticals to cutting-edge digital health solutions, the platform highlights key players, strategic partnerships, and transformative technologies shaping the future of healthcare. Serving as a trusted resource for industry professionals, thought leaders, and healthcare organizations, HealthTech Media Room is dedicated to driving conversations and knowledge sharing in the global HealthTech community.